InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.00%
)
US TECH 100
17,693.20
(
0.30%
)
Dow Jones
39,387.76
(
0.00%
)
Brent Oil
83.92
(
-0.04%
)
Bitcoin
62,972.78
(
-0.12%
)
Post# of 37544
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jedijazz

Send PM Follow Ignore
Followers 1322
Posts 247400
Boards Moderated 55
Alias Born 12/07/2009

jedijazz

Member Level

Re: None

Thursday, 04/19/2018 10:55:00 AM

Thursday, April 19, 2018 10:55:00 AM

Post# of 37544
$RGBP Regen BioPharma, Inc. Nears Completion Of Optimizing Its Lead NR2F6 Small Molecule Agonist "Company is preparing for efficacy experiments in mice" #FDA #StockInPlay @frontpagestocks
https://www.thestreet.com/story/14529815/1/regen-biopharma-inc-nears-completion-of-optimizing-its-lead-nr2f6-small-molecule-agonist.html


ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up